National Registry of Cardioneuroablation in Recurrent Reflex Syncope

Status: Recruiting
Location: See all (14) locations...
Intervention Type: Procedure
Study Type: Observational
SUMMARY

This registry aims to collect patient data on cardioneuroablation for vasovagal syncope from multiple centers in France. The aim is to evaluate success rates, compare techniques and help institutions set up their own cardioneuroablation program

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 100
Healthy Volunteers: f
View:

• Patients aged 18 or more

• Recurrent vasovagal syncope (≥2 episodes during the last year) with an asystolic component (≥3 second pause) recorded during a spontaneous episode. The asystole can be related to sinus arrest or paroxysmal AV block.

• Scheduled cardioneuroablation procedure

• Estimated residual battery life ≥ 1 year.

• Patient affiliated to or beneficiary of national health security scheme.

• Patient who have received an information notice and has not objected to the use of their data in the registry.

Locations
Other Locations
France
Hôpital Louis Pradel
RECRUITING
Bron
CHU Clermont-Ferrand
RECRUITING
Clermont-ferrand
CHU Lille
NOT_YET_RECRUITING
Lille
Hôpital de la Timone
RECRUITING
Marseille
CHU de Montpellier
NOT_YET_RECRUITING
Montpellier
Clinique du Millénaire
RECRUITING
Montpellier
Hôpital européen Georges Pompidou
RECRUITING
Paris
Hôpital Pitié-Salpêtriére
RECRUITING
Paris
Hôpital Haut-Lévèque
RECRUITING
Pessac
CHR Pontchaillou
RECRUITING
Rennes
Centre cardiologique du Nord
RECRUITING
Saint-denis
Institut ARNAULT TZANCK
NOT_YET_RECRUITING
Saint-laurent-du-var
CHU de Toulouse
RECRUITING
Toulouse
Clinique Pasteur
RECRUITING
Toulouse
Contact Information
Primary
Josselin DUCHATEAU
josselin.duchateau@chu-bordeaux.fr
+33 5 57 65 64 71
Time Frame
Start Date: 2024-11-27
Estimated Completion Date: 2026-01-31
Participants
Target number of participants: 50
Treatments
Cardioneuroablation
Cardioneuroablation
Sponsors
Leads: University Hospital, Bordeaux

This content was sourced from clinicaltrials.gov